(Nature) – The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers, raising hopes for a new therapeutic option for this devastating neurodegenerative disease and other autoimmune disorders. Physicians already treat blood cancer with the engineered cells, called CAR T cells. But these living drugs are not yet approved for use in other diseases. (Read More)